Novel agents in the treatment of chronic lymphocytic leukemia

6 years ago

By: Nishanth Viswanath, PharmD Candidate c/o 2022 Introduction   Chronic lymphocytic leukemia (CLL)  is a hematological malignancy of mature CD5 positive…

A Closer Glance at Mycobacterium Avium Complex (MAC) Infection and Treatment

6 years ago

By: Dana Weinstein, PharmD Candidate c/o 2022              Mycobacterium avium complex (MAC) infection in humans is caused by two main species, Mycobacterium…

Metastatic Breast CancER+ Treatment

6 years ago

By: Lyana Sayilar, PharmD Candidate c/o 2020 Approved on April 17, 2020, tucatinib (TukysaTM) is indicated to aid in the…

COVID-19 and the vaccine development process: A closer look

6 years ago

By: Jason Ifeanyi, PharmD Candidate c/o 2022 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the viral strain responsible for causing…

Issues of Stigma When Addressing Schizophrenia & Mental Illness

6 years ago

By: William Obilisundar, PharmD Candidate c/o 2023, Binghamton University School of Pharmacy and Pharmaceutical Sciences              One of the most…

When Epidemic Meets Pandemic: Treatment of Opioid Use Disorder Amidst Coronavirus Disease 2019 (COVID-19)

6 years ago

By: Preethi Samuel, PharmD Candidate c/o 2021, Aisa Mrkulic, PharmD. Candidate c/o 2022              Opioid use disorder (OUD) is a…

Usage of Ibuprofen and Angiotensin-Converting Enzyme Inhibitors (ACEi) in Coronavirus 2019 (COVID-19) Patients: Should They Be Used?

6 years ago

By: Evan Cheung, PharmD (c/o 2020)             On March 11th, 2020, a research article was published in the Lancet journal…

Dexamethasone and COVID-19

6 years ago

By:  Natalia Loomis, PharmD Candidate c/o 2022 The World Health Organization announced the official name “COVID-19” on February 11, 2020…

NIH COVID-19 Treatment Guidelines Update: remdesivir, chloroquine, hydroxychloroquine, and azithromycin

6 years ago

By: Jason Ifeanyi, PharmD Candidate c/o 2022 Severe acute respiratory syndrome 2 (Sars-Cov-2), the viral strain responsible for causing COVID-19,…

Brexanolone (Zulresso™) in the treatment of Postpartum Depression

6 years ago

By: Shivani Kaneria, Pharm D. Candidate c/o 2020 Postpartum depression is a mood disorder that affects 10 – 20 percent…